SEPARATION AND CONSULTING AGREEMENT This Separation and Consulting Agreement (the "Agreement") is entered into as of the 3rd day of January 2008, by and between NovaStar Financial, Inc., on behalf of itself and all of its direct and indirect...Separation and Consulting Agreement • January 8th, 2008 • Novastar Financial Inc • Real estate investment trusts
ContractSeparation and Consulting Agreement • May 5th, 2020 • New York
EX-10.9 9 exhibit109-separationandco.htm EXHIBIT EXHIBIT 10.9 SEPARATION AND CONSULTING AGREEMENT This SEPARATION AND CONSULTING AGREEMENT (the “Agreement”) is entered into as of September 30, 2012, by and between Robert Van de Vuurst (“the Executive”) and Era Group, Inc., a Delaware corporation (the “Company”), a wholly owned subsidiary of SEACOR Holdings Inc., a Delaware corporation (“SEACOR”). WHEREAS, the Executive has served as the Chief Operating Officer of the Company and as President of Era Helicopters, LLC; WHEREAS, the Company and the Executive are not parties to an employment agreement or other contractual understanding regarding the employment of the Executive, and the employment of the Executive is an “employment at will” and may be terminated at any time by either party for any reason; WHEREAS, the parties have determined by mutual agreement that the employment of Executive shall be terminated, and that the Executive shall continue in a consulting capacity with the Compan
January 31, 2024Separation and Consulting Agreement • February 6th, 2024 • Atreca, Inc. • Pharmaceutical preparations
This letter sets forth the substance of the separation and consulting agreement (the “Agreement”) that Atreca, Inc. (the “Company”) is offering to you to aid in your employment transition.
SEPARATION AND CONSULTING AGREEMENT AND GENERAL RELEASE OF CLAIMSSeparation and Consulting Agreement • December 22nd, 2023 • Spyre Therapeutics, Inc. • Pharmaceutical preparations • Texas
This SEPARATION AND CONSULTING AGREEMENT AND GENERAL RELEASE OF CLAIMS (this “Agreement”) is entered into by and between Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”), and Jonathan Alspaugh (“Executive”). Executive and the Company are each referred to herein as a “Party” and collectively as the “Parties.”
SEPARATION AND CONSULTING AGREEMENT AND RELEASE OF CLAIMSSeparation and Consulting Agreement • February 28th, 2024 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
This Separation and Consulting Agreement and Release of Claims (“Agreement”), dated as of December 15, 2023, is entered into by and between Myriad Genetics, Inc. (together with its subsidiaries, affiliates, successors and assigns, the “Company”) and R. Bryan Riggsbee (“Executive” and together with the Company, the “Parties” and each a “Party”).
Re: Separation and Consulting AgreementSeparation and Consulting Agreement • May 13th, 2021 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This letter agreement (this “Agreement”) summarizes the terms of the separation and consulting agreement that Lineage Cell Therapeutics, Inc. (“Lineage”) is offering to you in connection with your employment termination.
Separation and Consulting AgreementSeparation and Consulting Agreement • August 5th, 2015 • Alico Inc • Agricultural production-crops • Florida
THIS SEPARATION AND CONSULTING AGREEMENT (this “Agreement”), dated as of June 1, 2015, is entered into by and between Alico, Inc., a Florida corporation (the “Company”), and W. Mark Humphrey (the “Consultant”).
EX-10.1 2 d310335dex101.htm EX-10.1 Execution Version SEPARATION AND CONSULTING AGREEMENT AND GENERAL RELEASE OF CLAIMSSeparation and Consulting Agreement • May 5th, 2020 • Texas
This SEPARATION AND CONSULTING AGREEMENT AND GENERAL RELEASE OF CLAIMS (this “Agreement”) is entered into by and among Marc Carroll (“Carroll”) and Black Stone Natural Resources Management Company, a Delaware corporation (the “Company”). Black Stone Minerals GP, L.L.C., a Delaware limited liability company (the “General Partner”), joins this Agreement for the limited purpose of agreeing to Sections 2 and 3 below. The Company, the General Partner, and Carroll are each referred to herein individually as a “Party” and collectively as the “Parties.”
SEPARATION and CONSULTING AGREEMENTSeparation and Consulting Agreement • October 29th, 2018 • Ceridian HCM Holding Inc. • Services-prepackaged software • Ontario
Re:Separation and Consulting AgreementSeparation and Consulting Agreement • May 8th, 2018 • Alder Biopharmaceuticals Inc • Pharmaceutical preparations • Washington
This letter sets forth the terms of the separation and consulting agreement (the “Agreement”) which Alder BioPharmaceuticals, Inc. (the “Company”) is offering to you to aid in your employment transition.
EX-10.2 2 mram-20170930ex102cdba9d.htm EX-10.2 August 23, 2017 Phillip LoPresti Everspin Technologies Chandler, AZ 85224 Dear Phill:Separation and Consulting Agreement • May 5th, 2020 • Arizona
This letter sets forth the substance of the separation and consulting agreement (the “Agreement”) that Everspin Technologies, Inc. (the “Company”) is offering to you.
SEPARATION AND CONSULTING AGREEMENTSeparation and Consulting Agreement • May 24th, 2024 • Acadia Healthcare Company, Inc. • Services-specialty outpatient facilities, nec • Delaware
This Separation Agreement (this “Agreement”), dated May 23, 2024, is effective as of the “Effective Date” (as defined below), between Acadia Management Company, Inc. (the “Company”) and John Hollinsworth (“Employee” and with the Company, collectively, the “Parties”).
EX-10.1 2 d591613dex101.htm EX-10.1 June 3, 2018 William Lis Portola Pharmaceuticals, Inc. South San Francisco, CA 94080 Dear Bill:Separation and Consulting Agreement • May 5th, 2020 • California
This letter sets forth the substance of the transition, separation and consulting agreement (the “Agreement”) between you and Portola Pharmaceuticals, Inc. (the “Company”).
Re: Separation and Consulting AgreementSeparation and Consulting Agreement • May 10th, 2022 • Revance Therapeutics, Inc. • Pharmaceutical preparations • California
This letter sets forth the substance of the mutual separation agreement (the “Agreement”) that Revance Therapeutics, Inc. (the “Company”) is offering to you to aid in your employment transition.
EXHIBIT 10.3 Separation and Consulting Agreement Effective as of August 1, 2002, that parties hereto agree that the Employment Agreement made and entered into as of May 15, 2000, by and between The viaLink Company (the "Company") and Mark Bromberg...Separation and Consulting Agreement • August 14th, 2002 • Vialink Co • Services-computer programming services
EX-10.1 2 a18-18227_1ex10d1.htm EX-10.1 SEPARATION AND CONSULTING AGREEMENTSeparation and Consulting Agreement • May 5th, 2020 • Minnesota
This SEPARATION AND CONSULTING AGREEMENT (this “Agreement”) is made and entered into as of August 1, 2018 (the “Effective Date”) by and between Tactile Systems Technology, Inc., a Delaware corporation (the “Company”), and Lynn Blake, a resident of Minnesota (“Blake”).
EXHIBIT 10.4 SEPARATION AND CONSULTING AGREEMENT This Separation and Consulting Agreement (this "Agreement") is made and entered into on April 29, 2002, by and between SCB Computer Technology, Inc., a Tennessee corporation (the "Company"), and Lyle J....Separation and Consulting Agreement • July 26th, 2002 • SCB Computer Technology Inc • Services-computer programming services • Tennessee
SEPARATION AND CONSULTING AGREEMENTSeparation and Consulting Agreement • March 30th, 2021 • Andina Gold Corp. • Cutlery, handtools & general hardware • Colorado
THIS SEPARATION AGREEMENT AND CONSULTING (hereinafter referred to as the “Agreement”) is made and entered into effective as of February 26, 2020, by and between Christopher Hansen (as used herein, “Hansen”, which also includes Christopher Hansen and his legal representatives, agents, heirs, executors, administrators, successors and assigns), and Redwood Green Corp., its divisions, parents, subsidiaries, affiliates or related companies, its and their past, present and future officers, directors, shareholders, trustees, insurers, attorneys, legal representatives, employees and agents and all of its and their respective heirs, executors, administrators, and successors and assigns (hereinafter, “Company”) (Hansen and Company are collectively referred to herein as the “Parties”), for the following purpose and with reference to the following background information:
SEPARATION AND CONSULTING AGREEMENTSeparation and Consulting Agreement • June 14th, 2021 • Intest Corp • Instruments for meas & testing of electricity & elec signals • Delaware
This Separation and Consulting Agreement (the “Agreement”) is by and between inTEST Corporation (the “Company”) and Hugh T. Regan, Jr. (“Executive”).
ContractSeparation and Consulting Agreement • May 5th, 2020 • Texas
EX-10.1 2 a101-ceoseparationagreement.htm EXHIBIT SEPARATION AND CONSULTING AGREEMENT This SEPARATION AND CONSULTING AGREEMENT (the “Agreement”) is entered into as of August 28, 2014 by and between Sten L. Gustafson (the “Executive”) and Era Group Inc., a Delaware corporation (the “Company”). WHEREAS, the Executive has served as the President and Chief Executive Officer of the Company since April 2012; WHEREAS, the Company and the Executive are not parties to a written employment agreement or other contractual understanding regarding the employment of the Executive, and the employment of the Executive is an “employment at will” relationship and may be terminated at any time by either party for any reason; WHEREAS, the parties have determined by mutual agreement that the employment of Executive shall be terminated, and that the Executive shall continue in a consulting capacity with the Company, on the terms set forth in this Agreement; and WHEREAS, the parties agree to resolve any and a
January 9, 2020 Via Hand Delivery Jennifer Rhodes c/o Adamas Pharmaceuticals, Inc. Re: Separation and Consulting Agreement Dear Jennifer:Separation and Consulting Agreement • May 7th, 2020 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations • California
This letter sets forth the substance of the separation and consulting agreement (the “Agreement”) that Adamas Pharmaceuticals, Inc. (the “Company”) is offering to you to aid in your employment transition.
Exhibit 10.42 SEPARATION AND CONSULTING AGREEMENT This Separation and Consulting Agreement ("Agreement") is entered into as of April 15, 2003, by and among Columbia Laboratories, Inc., a Delaware corporation having a principal place of business at 345...Separation and Consulting Agreement • May 14th, 2003 • Columbia Laboratories Inc • Pharmaceutical preparations • New York
SEPARATION AND CONSULTING AGREEMENTSeparation and Consulting Agreement • February 3rd, 2015 • Landauer Inc • Measuring & controlling devices, nec • Delaware
This Separation and Consulting Agreement (“Agreement”) is made by and between Landauer, Inc. (“Landauer”), and William E. Saxelby (“Mr. Saxelby” or “Consultant”).
info@portola.com www.portola.com T: 650.246.7000 F: 650.246.7376 270 East Grand Avenue South San Francisco, CA 94080 Innovative Science. Patient Focused.Separation and Consulting Agreement • November 7th, 2018 • Portola Pharmaceuticals Inc • Pharmaceutical preparations
This letter sets forth the substance of the separation and consulting agreement (the “Agreement”) between you and Portola Pharmaceuticals, Inc. (the “Company”).
October 7, 2015 Adam Craig Sunesis Pharmaceuticals, Inc. South San Francisco, CA 94080 Dear Adam:Separation and Consulting Agreement • March 14th, 2016 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This letter sets forth the substance of the separation and consulting agreement (the “Agreement”) that Sunesis Pharmaceuticals, Inc. (the “Company”) is offering to you.
SEPARATION AND CONSULTING AGREEMENT (James Atchison)Separation and Consulting Agreement • February 27th, 2015 • SeaWorld Entertainment, Inc. • Services-miscellaneous amusement & recreation • Florida
This Separation and Consulting Agreement (the “Agreement”), dated as of December 10, 2014, is entered into by and between James Atchison (“Atchison”) and SeaWorld Entertainment, Inc. (together with its subsidiaries and affiliates, “SeaWorld”) (which, together with its predecessors, successors, officers and directors are collectively referred to as the “Beneficiaries”).
Re:Separation and Consulting AgreementSeparation and Consulting Agreement • August 5th, 2015 • Versartis, Inc. • Pharmaceutical preparations • California
This letter agreement (the “Agreement”) sets forth the terms of your separation and transition from Versartis, Inc. (“Versartis” or the “Company”).
SEPARATION AND CONSULTING AGREEMENTSeparation and Consulting Agreement • August 14th, 2000 • Minntech Corp • Surgical & medical instruments & apparatus • Minnesota
This Separation and Consulting Agreement (the "Agreement") is made and entered into on July 17, 2000 by and between Thomas J. McGoldrick ("McGoldrick"), a Minnesota resident, and Minntech Corporation ("Company"), a Minnesota corporation.
SEPARATION AND CONSULTING AGREEMENTSeparation and Consulting Agreement • August 2nd, 2013 • Amkor Technology Inc • Semiconductors & related devices • California
SEPARATION AND CONSULTING AGREEMENTSeparation and Consulting Agreement • May 24th, 2018 • Avis Budget Group, Inc. • Services-auto rental & leasing (no drivers) • New Jersey
This Separation and Consulting Agreement (the “Agreement”) is by and between Ronald L. Nelson (the “Executive”) and Avis Budget Group, Inc., a Delaware Corporation (the “Company”).
SEPARATION AND CONSULTING AGREEMENT AND GENERAL RELEASE OF CLAIMSSeparation and Consulting Agreement • December 22nd, 2017 • Huntsman CORP • Chemicals & allied products • Utah
This SEPARATION AND CONSULTING AGREEMENT AND GENERAL RELEASE OF CLAIMS (“Agreement”) is made and entered into by and between Huntsman Corporation, a Delaware corporation (the “Company”), and Jon M. Huntsman (“Consultant”), on December 19, 2017 (the “Effective Date”). The Company and Consultant are each referred to herein individually as a “Party” and collectively as the “Parties.”
Re: Amendment to Separation and Consulting AgreementSeparation and Consulting Agreement • November 5th, 2018 • Alder Biopharmaceuticals Inc • Pharmaceutical preparations • Washington
This letter agreement sets forth the amendment we discussed to your Separation and Consulting Agreement dated March 26, 2018 (the “Separation Agreement”), by and between you and Alder BioPharmaceuticals, Inc. (the “Company”). If you sign and return this amendment on or before September 21, 2018, the Separation Agreement will be amended as follows:
SEPARATION AND CONSULTING AGREEMENTSeparation and Consulting Agreement • September 30th, 2008 • Sovereign Bancorp Inc • Savings institution, federally chartered • Pennsylvania
This SEPARATION AND CONSULTING AGREEMENT (the “Agreement”) is entered into on September 30, 2008, by and between Sovereign Bancorp, Inc., a Pennsylvania corporation (the “Company”), and Joseph P. Campanelli (the “Executive”).
EXHIBIT 10.24 June 10, 1998Separation and Consulting Agreement • July 15th, 1998 • Rf Monolithics Inc /De/ • Radio & tv broadcasting & communications equipment • Texas
Onyx Pharmaceuticals, Inc. 2100 Powell Street Emeryville, California 94608 Tel 510.597.6500 Fax 510.597.6600 www.onyx-pharm.comSeparation and Consulting Agreement • February 23rd, 2011 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
This Noncompetition And Non-Solicitation Agreement (the “Noncompetition Agreement”) is being executed and delivered as of October 10, 2009, by Michael Kauffman M.D. (“Stockholder”), in favor of, and for the benefit of: Onyx Pharmaceuticals, Inc., a Delaware corporation (“Parent”), and the other Beneficiaries. Certain capitalized terms used in this Noncompetition Agreement are defined in Section 14.
